I would like to see the dental bring us cash flow neutral, that would be a very good achievement and set the company up for years to come. I would have thought we may have had a distribution agreement by now. Maybe the surprise early fda approval caught them off guard.
- Forums
- ASX - By Stock
- Further CelGro® nerve clinical trial data from all patients at 12 months
I would like to see the dental bring us cash flow neutral, that...
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
65.0¢ |
Change
-0.035(5.11%) |
Mkt cap ! $156.6M |
Open | High | Low | Value | Volume |
67.0¢ | 67.0¢ | 65.0¢ | $225.2K | 340.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 30233 | 65.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
65.5¢ | 4000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 30233 | 0.650 |
3 | 17400 | 0.645 |
10 | 102613 | 0.640 |
6 | 61094 | 0.635 |
8 | 116388 | 0.630 |
Price($) | Vol. | No. |
---|---|---|
0.655 | 4000 | 2 |
0.660 | 13434 | 3 |
0.665 | 37853 | 4 |
0.670 | 18933 | 3 |
0.675 | 10850 | 2 |
Last trade - 15.40pm 13/11/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online